Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer.
      QxMD      Google Scholar   
Citation:
Cancer Discov vol 7 (10) 1168-83
Year:
2017
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
7
Parents:
None
Children:
None
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180833, U10CA180858, RP120092, P30CA125123, R01 CA095614, T32 GM088129, U10 CA180821, U24 CA196171, U10 CA180882, U10 CA077440, U10 CA180833, U10 CA180858, P30 CA125123  
Corr. Author:
 
Authors:
                                       
Networks:
CA087, GA005, HEARTLAND, LAPS-MO011, LAPS-OK003, LAPS-TX035, NJ032, TX041   
Study
ACOSOG-Z1031
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: